KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Gilead Sciences' Net Income towards Common Stockholders rose 14357.54% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 billion, marking a year-over-year increase of 707699.12%. This contributed to the annual value of $479.0 million for FY2024, which is 9146.47% down from last year.
  • Per Gilead Sciences' latest filing, its Net Income towards Common Stockholders stood at $3.1 billion for Q3 2025, which was up 14357.54% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Net Income towards Common Stockholders registered a high of $3.1 billion during Q3 2025, and its lowest value of -$4.2 billion during Q1 2024.
  • For the 5-year period, Gilead Sciences' Net Income towards Common Stockholders averaged around $1.2 billion, with its median value being $1.5 billion (2021).
  • In the last 5 years, Gilead Sciences' Net Income towards Common Stockholders surged by 810000.0% in 2023 and then plummeted by 52388.21% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Net Income towards Common Stockholders stood at $376.0 million in 2021, then soared by 334.31% to $1.6 billion in 2022, then dropped by 13.29% to $1.4 billion in 2023, then increased by 25.85% to $1.8 billion in 2024, then skyrocketed by 71.27% to $3.1 billion in 2025.
  • Its Net Income towards Common Stockholders was $3.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.3 billion in Q1 2025.